# Gallbladder Mucocele in Dogs: Necrosis Risk, Ultrasound and Surgery ## Key Takeaways - Gallbladder mucocele (GBM) in dogs is a muco-obstructive disease caused by abnormal mucus secretion and dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR), leading to dehydrated, viscous mucus, rather than mucin overproduction. - Ultrasonography is the gold standard for diagnosing GBM, identifying characteristic immobile, stellate bile; however, it cannot reliably predict necrosis or rupture, which are significant risk factors for increased mortality. - Necrotizing cholecystitis, a histopathologic finding, is strongly associated with increased 30-day mortality post-cholecystectomy, and gallbladder rupture significantly increases the likelihood of death. - Cholecystectomy is the definitive treatment, but carries a notable 30-day mortality rate of approximately 14.6%, with higher risks in dogs exhibiting preoperative leukopenia, abdominal effusion, or elevated C-reactive protein. - Concurrent endocrinopathies, particularly hypothyroidism and hyperadrenocorticism, and hyperlipidemia are strongly associated with GBM and significantly increase the risk of gallbladder rupture. - Long-term prognosis is generally good for survivors of cholecystectomy, but concurrent hepatic fibrosis or neutrophilic cholangiohepatitis can negatively impact outcomes. --- **Owner Triage Summary:** If your [dog](/knowledge/veterinary-medicine/clinical-methods/dog) has been diagnosed with a gallbladder mucocele (GBM), the most critical decisions involve the risk of gallbladder necrosis or rupture and the timing of surgery. Ultrasonography is the cornerstone of diagnosis, but it cannot always predict which gallbladders are already compromised. Cholecystectomy (surgical removal of the gallbladder) is the definitive treatment, yet it carries a significant short-term mortality risk, especially in dogs with preoperative complications like abdominal effusion or leukopenia. This article provides a detailed, evidence-based overview of the pathophysiology, diagnostic imaging, surgical considerations, and prognostic indicators for this challenging disease. ## At a Glance: Key Clinical Decisions in Canine Gallbladder Mucocele | Factor | Clinical Significance | Source Support | | :--- | :--- | :--- | | **Diagnosis** | Ultrasound showing non-gravity-dependent, stellate or immobile bile is the standard for antemortem diagnosis. | [1] | | **Necrosis Risk** | Necrotizing cholecystitis is a histopathologic finding strongly associated with increased 30-day mortality post-cholecystectomy. | [2] | | **Rupture Risk** | Gallbladder rupture is a severe complication. Dogs with rupture are 3.2 times more likely to die than those without. | [3] | | **Surgical Mortality** | The 30-day mortality rate after cholecystectomy for GBM is approximately 14.6%, with higher risk in dogs with preoperative leukopenia, abdominal effusion, or elevated C-reactive protein. | [2] | | **Surgical Technique** | Use of a bipolar vessel-sealing device (BVSD) for cystic duct ligation has similar complication rates to traditional ligation methods. | [4] | | **Prognosis** | Long-term prognosis is good for dogs that survive the perioperative period, but concurrent hepatic fibrosis or neutrophilic cholangiohepatitis can affect outcomes. | [5], [6] | ## Understanding the Disease: Pathogenesis of Gallbladder Mucocele Gallbladder mucocele formation is a major cause of biliary disease in dogs, particularly affecting older, small-breed purebreds [7][1]. For years, it was assumed that the condition resulted from the overproduction of mucin. However, recent molecular and functional studies have fundamentally changed this understanding. ### The Role of Abnormal Mucus Secretion and CFTR Dysfunction Current evidence indicates that GBM is not a disease of mucin overproduction, but rather a muco-obstructive disease caused by the secretion of abnormal mucus, with a pathology bearing striking similarity to cystic fibrosis in humans [1][8]. Research has demonstrated that the excessive accumulation of mucin is not due to overproduction by gallbladder epithelial cells (GBECs) [9][10]. Instead, there is a significant loss of anion secretion, specifically a dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) [8]. This acquired dysfunction of CFTR leads to decreased fluid and bicarbonate secretion into the gallbladder lumen. The resulting dehydrated, hyper-concentrated mucus becomes abnormally viscous and adheres to the gallbladder wall, eventually forming the characteristic immobile "mucocele" [1][8]. Studies using canine gallbladder cholangiocyte organoids (GCOs) have confirmed that the function of CFTR and calcium-activated chloride channels (CaCCs) is significantly impaired in GBM-affected gallbladders compared to healthy ones, even when gene expression levels are similar [11]. This points to a post-translational or functional defect rather than a simple genetic downregulation. ### The Lipid Connection The pathogenesis of GBM is also closely linked to metabolic dysfunction. A unique lipidomic signature has been identified in dogs with GBM, characterized by increased lipogenesis and lipidosis of the gallbladder epithelium [12]. This finding connects the disease to common concurrent conditions like hyperlipidemia, hyperadrenocorticism, and hypothyroidism [1][12]. The gallbladder epithelium itself undergoes severe lipid accumulation, suggesting a local metabolic disturbance that may contribute to the functional failure of the epithelial cells. ## Risk Factors and Predispositions Gallbladder mucocele formation has a clear predilection for certain populations. - **Breed:** Small-breed dogs are overrepresented. Toy Poodles are particularly at risk, with one study showing they were 3.1 times more likely to be affected [7]. Other small terrier breeds and Shetland Sheepdogs are also commonly cited as predisposed. - **Age:** The disease typically affects older dogs, with a mean age of around 11 years in some studies [13]. - **Endocrinopathies:** There is a strong association with concurrent endocrine disorders. Hypothyroidism, hyperadrenocorticism (Cushing's disease), and hyperlipidemia are frequently diagnosed in dogs with GBM [1]. Critically, the presence of hypothyroidism or pancreatitis significantly increases the risk of gallbladder rupture and death in small-breed dogs undergoing cholecystectomy [3]. Dogs with concurrent hypothyroidism are 4.1 times more likely to develop a gallbladder rupture, and dogs with pancreatitis are 2.6 times more likely [3]. ## Clinical Signs and Physical Examination The clinical presentation of a dog with a gallbladder mucocele can vary from asymptomatic (subclinical) to critically ill with septic peritonitis. Many dogs are diagnosed incidentally during an ultrasound for another reason. When clinical signs are present, they are often non-specific and relate to the gastrointestinal or hepatobiliary systems. Common signs include: - Anorexia or decreased appetite - Vomiting - Lethargy - Abdominal pain - Diarrhea or diarrhoea (in some cases) - Fever (more common with cholecystitis or rupture) - Icterus (jaundice), which may be present if there is extrahepatic biliary obstruction Physical examination may reveal a painful abdomen, dehydration, and in cases of rupture, signs of shock. However, these signs are not specific to GBM and can be seen with many other conditions, such as pancreatitis or gastroenteritis. ## Diagnostic Evaluation: The Role of Ultrasound Ultrasonography is the primary and most reliable diagnostic tool for gallbladder mucocele [1]. The characteristic finding is a distended gallbladder filled with immobile, echogenic bile that is adherent to the gallbladder wall. This bile often has a distinctive "stellate" or "kiwi-fruit" appearance on a transverse view, created by the central echogenic core and radiating spokes of mucus. The bile does not move with changes in patient position, which differentiates it from dependent, gravity-moving sludge. ### Beyond Diagnosis: Ultrasound as a Prognostic Indicator While ultrasound is excellent for diagnosis, its role in predicting complications like necrosis or rupture is more nuanced. - **Abdominal Effusion:** The presence of free abdominal fluid on preoperative ultrasound is a significant negative prognostic indicator. It is associated with a higher 30-day mortality rate following cholecystectomy [2]. However, not all effusion is due to bile peritonitis. - **Gallbladder Wall Integrity:** Ultrasound may identify a loss of wall continuity, which is highly suggestive of rupture. However, a normal-appearing wall does not rule out microscopic rupture or impending necrosis. In one study, the use of the abdominal fluid bilirubin-to-serum bilirubin ratio (AFB:SB) frequently failed to detect biliary tract rupture in dogs with GBM, even when rupture was present [14]. This highlights the limitation of relying solely on fluid bilirubin concentration. Cytological analysis of the abdominal fluid, which can confirm the presence of bile-laden macrophages or crystals, proved to be more valuable in detecting rupture in these cases [14]. - **Differentiating from Other Diseases:** Ultrasound is also useful for differentiating a mature GBM from other gallbladder diseases, such as gallbladder masses, polyps, or simple biliary sludge. A recent study compared dogs undergoing cholecystectomy for mature GBM versus "other gallbladder disease" and found that while the two groups had different clinical profiles, surgical outcomes and complication rates were not significantly different [13]. ## The Critical Risk: Necrosis and Rupture The most feared complications of gallbladder mucocele are gallbladder necrosis and rupture, which lead to bile peritonitis, a life-threatening condition. ### Necrotizing Cholecystitis Necrosis of the gallbladder wall, termed necrotizing cholecystitis, is a histopathologic finding that carries a poor prognosis. In a study of 41 dogs undergoing cholecystectomy for GBM, necrotizing cholecystitis was significantly associated with increased 30-day mortality [2]. The presence of necrosis indicates that the gallbladder wall has lost its blood supply and structural integrity, making it highly susceptible to rupture. ### The Cascade to Rupture The progression from mucocele formation to rupture is thought to be driven by increasing intraluminal pressure and ischemia of the gallbladder wall. The abnormal, inspissated mucus cannot be expelled, leading to progressive distension. This distension compromises blood flow to the wall, leading to necrosis and eventual rupture. The clinical consequences of rupture are severe. It often results in a septic and sterile bile peritonitis, which can rapidly progress to systemic inflammatory response syndrome (SIRS) and shock. Dogs with gallbladder rupture are significantly more likely to die than those without rupture [3]. The presence of a concurrent intramural haematoma, a rare finding, can also be a site of rupture, as seen in a case of a ruptured gallbladder mucocele with a concurrent ruptured intramural haematoma [15]. ## Surgical Management: Cholecystectomy Cholecystectomy is the definitive treatment for gallbladder mucocele [1]. The decision to proceed with surgery is often based on the presence of clinical signs, the size and appearance of the mucocele on ultrasound, and the risk of rupture. Elective cholecystectomy is increasingly recommended even for subclinical GBM, especially in high-risk patients, to prevent the high mortality associated with emergency surgery for rupture [3]. ### Surgical Techniques and Intraoperative Considerations The standard approach is an open cholecystectomy, although laparoscopic techniques are being explored. The surgery involves careful dissection of the gallbladder from the hepatic fossa, followed by ligation and division of the cystic duct and artery. - **Cystic Duct Ligation:** The method of cystic duct ligation does not appear to significantly influence short-term outcomes. A study comparing a bipolar vessel-sealing device (BVSD) to traditional ligation methods (sutures or clips) found no statistical difference in the rate or severity of perioperative or short-term complications [4]. - **Intraoperative Cholangiography:** Evaluating the patency of the common bile duct (CBD) is crucial to ensure that no inspissated mucus or calculi are obstructing bile flow after the gallbladder is removed. Intraoperative cholangiography (IOC) using indocyanine green (ICG) and near-infrared fluorescence (NIRF) has been shown to be an effective and easy method to assess CBD patency in real-time [16][17]. This technique can help surgeons decide if additional procedures, such as CBD catheterization or flushing, are necessary. In one case, a partial obstruction was identified and resolved by gentle external manipulation, avoiding the need for more invasive procedures [17]. - **Anatomical Risks:** Surgeons must be aware of the potential for anatomical variations, particularly the proximity of the middle hepatic vein (MHV) to the gallbladder fossa. In some dogs, branches of the MHV can lie immediately adjacent to the gallbladder wall, and dissection can result in sudden, massive hemorrhage [18]. Preoperative imaging, such as computed tomography (CT), can help identify this risk and guide surgical planning to avoid catastrophic bleeding [18]. ### The Decision for Surgery in Subclinical Cases Medical management with hepatoprotectants is sometimes considered for dogs with subclinical GBM (no clinical signs). A study evaluating different hepatoprotectant protocols found that a combination of ursodeoxycholic acid (UDCA), S-adenosylmethionine (SAMe), and silymarin was most effective at improving liver enzyme activities and reducing gallbladder sludge percentage [19]. However, this is not a cure, and the risk of progression to rupture remains. Given the high mortality associated with rupture, elective cholecystectomy is often the preferred recommendation, particularly for dogs with concurrent endocrinopathies that increase rupture risk [3]. ## Postoperative Prognosis and Predictors of Mortality The short-term mortality rate following cholecystectomy for GBM is significant. A recent single-centre study reported a 30-day mortality rate of 14.6% [2]. The long-term prognosis for dogs that survive the perioperative period is generally good. Several factors have been identified as predictors of poor short-term outcome: - **Preoperative Leukopenia:** A low white blood cell count before surgery is a strong predictor of mortality [2]. - **Elevated C-Reactive Protein (CRP):** Dogs with a preoperative CRP > 0.8 mg/dL have a significantly higher 30-day mortality rate compared to those with normal levels [2]. - **Abdominal Effusion:** The presence of free abdominal fluid on preoperative ultrasound is associated with a higher risk of death [2]. - **Necrotizing Cholecystitis:** This histopathologic finding is a significant predictor of mortality [2]. Long-term survival is also influenced by the degree of concurrent hepatic disease. Liver histopathology is almost always abnormal in dogs with GBM. Hepatic fibrosis, biliary hyperplasia, and portal inflammation are common findings [5]. The severity of hepatic fibrosis is associated with decreased survival at 1, 3, and 12 months post-cholecystectomy [5]. Similarly, the severity of neutrophilic cholangiohepatitis is correlated with higher preoperative bilirubin levels and reduced postoperative survival [6]. ## Medical Management and the Role of Hepatoprotectants For dogs that are not surgical candidates or for those with subclinical disease where surgery is declined, medical management may be attempted. The evidence base for medical therapy is still evolving. A 2025 study evaluated the effects of different hepatoprotectants on disease progression in subclinical GBM [19]. The study found that a triple combination therapy of UDCA, SAMe, and silymarin (Group 3) was the most effective, leading to significant reductions in liver enzymes (GGT, ALP, ALT, AST) and a decrease in gallbladder sludge percentage over a 365-day period [19]. The group receiving UDCA alone showed only mild improvement, while the group receiving SAMe and silymarin had minimal impact [19]. It is critical to understand that medical management does not resolve the mucocele. It may slow the progression of the disease and improve liver values, but the risk of rupture remains. This approach requires regular monitoring with repeat ultrasounds and blood work. This is not a substitute for surgery in symptomatic dogs or those at high risk of rupture. ## The Role of Bile Culture and Antimicrobials Bacterial infection of the gallbladder is a concern, especially in cases of cholecystitis or rupture. Bile culture results from dogs undergoing cholecystectomy for GBM show a positive rate of about 21.3% [7]. The most common isolates are *Escherichia coli* and *Enterococcus* spp. [7]. A significant concern is the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria. One study found that approximately 18% of isolates were MDR or XDR, with reduced susceptibility to beta-lactams but retained sensitivity to imipenem and florfenicol [7]. Interestingly, the same study found that antibiotic matching (choosing an antibiotic based on culture and susceptibility results) was not significantly associated with complications or length of hospital stay [7]. This suggests that the role of antibiotics in uncomplicated GBM surgery may be primarily for prophylaxis, and their use should be guided by local resistance patterns and the clinical status of the patient. ## Prevention and Surveillance Prevention of gallbladder mucocele is challenging because the underlying cause is not fully understood. However, managing known risk factors is prudent. - **Endocrine Disease:** Early diagnosis and management of hypothyroidism and hyperadrenocorticism may help reduce the risk of GBM development or progression [3][1]. - **Diet and Weight:** Given the association with hyperlipidemia and metabolic dysfunction, maintaining a healthy body weight and feeding a diet appropriate for the dog's age and health status may be beneficial [12]. - **Monitoring:** For breeds at high risk (e.g., Toy Poodles, Shetland Sheepdogs) or dogs with known endocrinopathies, regular abdominal ultrasound screening could be considered to detect GBM at an early, subclinical stage when elective surgery has the best outcomes. ## Limitations and When to Contact a Veterinarian This article provides a comprehensive overview, but it cannot predict the specific outcome for an individual dog. Breed-level information, while useful for assessing risk, cannot determine if a particular dog will develop a mucocele, experience necrosis, or survive surgery. The decision to proceed with surgery is complex and must be made in consultation with a veterinary surgeon or internal medicine specialist, taking into account the dog's overall health, age, laboratory values, and imaging findings. **Contact your veterinarian or an emergency veterinary clinic immediately if your dog exhibits any of the following:** - Repeated or severe vomiting - Severe lethargy or collapse - Abdominal pain or distension - Pale or jaundiced (yellow) gums - Difficulty breathing - Anorexia lasting more than 24 hours Early intervention is critical for improving the chances of a positive outcome in dogs with gallbladder mucocele. ## Frequently Asked Questions ### 1. What is the survival rate for dogs after gallbladder mucocele surgery? The 30-day mortality rate after cholecystectomy for gallbladder mucocele is approximately 14.6%, meaning about 85% of dogs survive the immediate postoperative period [2]. The long-term prognosis is generally good for those that recover from surgery, though it is influenced by the severity of concurrent liver disease [5][6]. ### 2. Can a gallbladder mucocele in a dog be treated without surgery? Medical management with hepatoprotectants like UDCA, SAMe, and silymarin can be attempted for subclinical mucoceles, and a triple combination therapy has shown some benefit in improving liver values and reducing sludge [19]. However, this does not cure the mucocele, and the risk of rupture remains, making surgery the definitive treatment [1]. ### 3. What are the first signs of a gallbladder mucocele in dogs? The first signs are often non-specific and include decreased appetite, vomiting, lethargy, and abdominal pain [15]. Some dogs may show no signs at all, and the mucocele is an incidental finding during an ultrasound for another reason [1]. ### 4. How is a gallbladder mucocele diagnosed in a dog? The diagnosis is primarily made using abdominal ultrasound, which shows a distended gallbladder with immobile, stellate bile that is adherent to the wall [1]. This characteristic appearance is considered diagnostic. ### 5. What causes gallbladder mucocele in dogs? The exact cause is unknown, but it is linked to a dysfunction of the CFTR protein in the gallbladder epithelium, leading to abnormal mucus secretion and decreased fluid secretion [8]. It is also strongly associated with metabolic and endocrine disorders like hyperlipidemia, hypothyroidism, and hyperadrenocorticism [1][12]. ### 6. Which dog breeds are most at risk for gallbladder mucocele? Small-breed dogs are at higher risk, with Toy Poodles being significantly overrepresented [7]. Other breeds like Shetland Sheepdogs and small terriers are also commonly affected [1]. ### 7. What is the risk of gallbladder rupture with a mucocele? The risk of rupture is significant, especially in dogs with concurrent hypothyroidism or pancreatitis, which are 4.1 and 2.6 times more likely to rupture, respectively [3]. Rupture leads to bile peritonitis and is associated with a high mortality rate, making dogs with rupture 3.2 times more likely to die [3]. ### 8. Is gallbladder mucocele a painful condition for dogs? Yes, gallbladder mucocele can cause abdominal pain, which is a common clinical sign [15]. The pain is often due to distension of the gallbladder, inflammation of the gallbladder wall (cholecystitis), or the development of peritonitis if rupture occurs.